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Abstract
The use of pedicled buccal fat pad flap (BFP) has proved of value for the closure of oroantral and oronasal com-
munications and is a well-established tool in oral and maxillofacial surgery. Otherwise, the perceived limitations 
of surgical therapy for bisphosphonate-related osteonecrosis of the jaws (BRONJ) have been widely discussed, 
and recommendations have largely been made to offer aggressive surgery only to stage 3 patients refractary to 
conservative management. Oroantral communication may be a common complication after sequestrectomy and 
bone debridement in upper maxillary BRONJ. We report a case series of stage 3 recalcitrant maxillary BRONJ 
surgically treated with extensive sequestrectomy and first reconstruction using pedicled BFP. All the cases pre-
sented an uneventful postoperative healing was uneventful without dehiscence, infection, necrosis or oroantral 
communication. We postulate that managing initially the site with BFP and primary closure may ensure a suf-
ficient blood supply and adequate protection for an effective bone-healing response to occur. This technique may 
represent a mechanic protection and an abundant source of adipose-derived adult stem cells after debridement in 
upper maxillary BRONJ. We evaluate in this work results, advantages and indications of this technique.
Key words: Buccal fat pad flap, bisphosphonate-related osteonecrosis of the jaws, oroantral communications, 
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Introduction
A pedicled buccal fat pad flap (BFP) was first described 
by Egyedi in 1977 for the closure of oroantral (OACs) 
and oronasal communications secondary to oncologic 
resections (1). During the past 3 decades, it has proved 
of value for the closure of OACs and is a well-establish-
ed tool in oral and maxillofacial surgery. It has been 
used as a pedicled graft in facial augmentation proce-
dures, for the repair of persistent oroantral fistulas after 
dental extractions, and in the treatment of oral submu-
cous fibrosis (2,3).
Bisphosphonate-related osteonecrosis of the jaws 
(BRONJ) is an enigmatic pathologic entity that was 
described in the scientific literature initially in 2003 
by Marx et al. (4) A clinical stage classification has 
been proposed, based on clinical symptoms (mainly 
pain) and the presence of lesions and complications 
such as jaw fractures, bone sequestrum and skin fis-
tulas by Ruggiero et al. (5) Treatment strategies varies 
depending stage of BRONJ, although literature regard-
ing the treatment of an established disease (stage 3) 
is not conclusive. American Association of Oral and 
Maxillofacial Surgeons (AAOMS) purpose conserva-
tive debridement, including resection, combined with 
antibiotic therapy in these patients (6). Recently, some 
authors describe high success rates developing aggres-
sive resections (7,8). 
OACs may be a common complication after sequestrec-
tomy and bone debridement in upper maxillary BRONJ, 
avoiding spontaneous healing and results in chronic fis-
tulas. We evaluate the use of BFP for first reconstruc-
tion of refractary maxillary BRONJ surgically treated 
with extensive sequestrectomy. The effectiveness of 
this technique for OAC prevention, advantages and in-
dications are discussed.
Case Series
Three cases of stage 3 maxillary BRONJ are presented. 
They were diagnosed and surgically treated with se-
questrectomy and reconstruction using pedicled BFP 
and primary mucosal closure at the Oral and Maxillofa-
cial Department of University Central Hospital between 
2008 and 2009.
-Case 1
A 62-year-old woman presented in March 2008 with 
pain and swelling in the left upper molar region. The 
patient presented history of breast cancer diagnosed in 
2000 treated with zoledronate (Zometa®, 4 mg IV once 
every 1 month) for 24 months, from 2005 to 2007. She 
underwent first upper molar extraction in another centre 
in January 2008. 
Intraoral examination revealed swelling and infection 
at the same site of molar extraction, but any bone ex-
posure was observed (Fig. 1.A). Panoramic radiograph 
was not conclusive, but Computed Tomography (CT) 
images revealed an 8.9 mm bone sequestrum in the 
affected area (Fig. 1.B).
A diagnosis of BRONJ stage 3 was made. We applied 
medical therapy: amoxicillin (4 gr/day) and clavulanate 
(250 mg/day) was started and continued for 15 days. 
Mouth-washes with chlorexidine and hydrogen peroxide 
were also prescribed. Then, sequestrectomy and bone de-
bridement was performed under general anaesthesia. 
Surgical technique
Intraoperatively, an incision was made in the superior 
vestibular sulcus at about 10 mm from the inserted gin-
giva beginning at the level of the upper second molar, 
exposing the maxillary periosteum and the BFP. The fat 
pad was delivered into the mouth by pulling it by blunt 
dissection, rotated and transferred onto the maxillary 
defect (Fig. 1.C). The overlying mucosa was sutured 
over the BFP without tension (Fig. 1.D). 
Postoperative healing was uneventful. No dehiscence, 
infection, or necrosis was observed (Fig. 1E). No oroan-
tral communication was observed. No new oral lesions 
were observed after 20-months carefully follow-up. 
-Case 2
A 64-year-old woman was referred in January 2009 by 
her oncologist for diagnosis of a painful oral lesion. Her 
past medical history included breast cancer since 1999, 
treated monthly with intravenous zoledronate infu-
sions, at a dose of 4 mg, from 2006 to 2008. Three years 
after initiating therapy with zoledronate, the patient 
complained of discomfort and drainage in the edentu-
lous left upper molar area. The patient did not report 
previous tooth extraction, and found it difficult to eat, 
speak, and perform oral hygiene. Intraoral examination 
revealed that the alveolar bone of the edentulous poste-
rior maxilla was exposed with a purulent discharge (Fig. 
2.A). The surrounding soft tissue was erythematous and 
edematous. CT images revealed a bone sequestrum and 
third upper molar impacted in the affected area (Figs. 
2.B-C), and diagnosis of BRONJ stage 3 was made.
Medical therapy with amoxicillin (4 gr/day), clavulanate 
(250 mg/day) and chlorexidine mouth-washes were 
started and continued for 15 days. Then, sequestrectomy 
and third molar extraction was performed under general 
anaesthesia. Intraoperatively, reconstruction using BFP 
was performed as described in Case 1 (Figs. 2.D-E).
Postoperative healing was uneventful with complete 
healing one month after surgery. No new oral lesions 
were observed after 10-months carefully follow-up. 
-Case 3
A 54-year-old woman presented in April 2005 with pain 
and swelling in the posterior right side of the maxilla. 
The patient reported first right maxillary molar extrac-
tion three months before. Clinical inspection showed a 
2mm fenestration that exposed a whitish necrotic cen-
tre in the affected area. Computed tomography (CT) 
showed right maxillary bone sequestrum. Eighteen 
Med Oral Patol Oral Cir Bucal. 2012 Mar 1;17 (2):e236-41.                                                                                                                                                      Pedicled buccal fat pad in osteonecrosis
e238
months before she had had multiple myeloma (isotype 
IgG) that had been treated with zoledronate (Zometa® 
4mg given intravenously every 3 weeks). 
A diagnosis of BRONJ stage 3 of the jaws was made. In 
August 2005 zoledronate was discontinued in consulta-
tion with her oncologist. It was performed sequestrec-
tomy and bone debridement under general anaesthesia. 
The overlying mucosa was sutured over the defect with-
out reconstruction with BFP. There had been oroantral 
communication after sequestrectomy in the early post-
operative period, closing completely at 8-week follow-
up. Treatment with zoledronate was not restarted.
She was followed-up annually. In October 2007 she de-
veloped pathological fractures of the bilateral humerus 
and right femur that were treated with an intramedu-
llary nail that was locked with proximal and distal inter-
locking screws. Then, the oncologist restarted therapy 
with zoledronate (Zometa® 4mg given intravenously 
every month).
The patient was carefully followed-up and in July 2009 
referred pain and swelling in the upper left edentulous 
maxillary area. The clinical finding was an area of ul-
cerated mucosa and exposed devitalized bone (Fig. 3.A) 
and CT images revealed a large bone sequestrum (Fig. 
3.B). Then, the patient underwent surgical bone debri-
dement and sequestrectomy under general anaesthesia, 
and reconstruction using BFP was performed as des-
cribed in Case 1 (Figs. 3.C-E).
After this second surgery, no oroantral communica-
tion was observed and the patient showed acceptable 
healing and resolution of their disease 6 weeks after 
surgery. The patient died 7 months after surgery of her 
systemic disease.
Fig. 1. A) Photograph showing swelling area in upper left maxilla 
without bone exposure.
Fig. 1. B) CT image demonstrating bone sequestrum of 8.9 mm di-
ameter in the affected area (red arrow).
Fig. 1. C) Surgical approach after bone debridement 
using pedicled BFP and transferring into maxillary 
defect.
Fig. 1. D) Photograph showing suture of the mucosa over BFP with-
out tension.
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Fig. 1. E) Clinical image six months after surgery.
Fig. 2. A) Clinical image revealing alveolar bone exposure of the 
edentulous posterior maxilla with a purulent discharge.
Fig. 2. B) Sagital CT image demonstrating bone sequestrum and 
third molar inclusion (red arrow).
Fig. 2. C) Axial CT image showing large sequestrum around third 
molar included (red arrow).
Fig. 2. D) Surgical approach after bone debridement using pedicled 
BFP into maxillary defect.
Fig. 2. E) Photograph showing suture of the mucosa over BFP with-
out tension.
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Fig. 3. A) Photograph showing exposed devitalized 
bone in the upper left edentulous maxillary area.
Fig. 3. B) CT image demonstrating a large bone sequestrum in the 
affected area (red arrow).
Fig. 3. C) Photograph of the surgical approach showing bone seques-
trum before debridement.
Fig. 3. D) The fat pad was delivered into the mouth by pulling it by 
blunt dissection, rotated and transferred onto the maxillary defect.
Fig. 3. E) Photograph showing final suture of the mucosa over BFP 
without tension.
Discussion
The successful application of BFP has been documented 
for reconstruction of the palatal region, buccal mucosa, 
closure of oronasal fistulas, coverage of the surface of bone 
grafts, and reconstruction after post-traumatic or oncolo-
gic defects in the maxillary region (9-12). Hao (9) reported 
that the ideal defects to be reconstructed with a BFP are 
the maxillary defects due to their close anatomical loca-
tion. However, it can be applied in areas ranging from the 
mouth angle to the retromolar trigone and palate.
The BFP separates the masticatory muscles. The fat tissue 
is of the syssarcosis type, not subject to lipid metabolism, 
resembling periorbital fat tissue and can be easily distin-
guished from subcutaneous fat tissue. The BFP consists 
of an encapsulated body with 4 extensions: buccal, ptery-
goid, superficial, and deep temporal. The blood supply 
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to the BFP derives from the buccal and deep temporal 
branches of the maxillary artery, from the transverse fa-
cial branch of the superficial temporal artery, and from 
some small branches of the facial artery (13).
The perceived limitations of surgical therapy for BRONJ 
have been discussed extensively in the literature, and re-
commendations have largely been made to offer conser-
vative therapy to patients, with aggressive surgery offered 
only to stage 3 patients refractary to conservative mana-
gement (6,14). Otherwise, many cases do not respond to 
conservative management and the infection and bone de-
struction are progressive. Williamson (8) have proposed 
surgical management of BRONJ included debridement 
of all necrotic bone, surgical smoothing of the irregular 
bony areas, tension free primary closure of the wound 
site with pre and postoperative antibiotics for recalcitrant 
cases. Carlson et al. (7) described that healing is particu-
larly predictable after resection of the maxilla and man-
dible in patients in whom BRONJ develops related to a 
parenteral or an oral bisphosphonate medication. Thus, 
more aggressive surgery may represent an effective ma-
nagement of stage 3 BRONJ patients. 
When BRONJ area or bone sequestrum is localized in 
upper maxilla and surgery treatment is planned, OAC 
must be considered as a potential complication. We pos-
tulate that managing the site with BFP and primary clo-
sure may ensure a sufficient blood supply and adequate 
protection for an effective bone-healing response to 
occur. The BFP must be gently brought into the surgi-
cal defect while maintaining the vascular pedicle and it 
must not be sutured under tension. This flap provides 
a rich vascularization in the BRONJ site, a mechanic 
protection and an abundant source of adipose-derived 
adult stem cells. Those cells have been widely used 
in bone engineering due their capacity to differentiate 
along multiple mesodermal lineage pathways and form 
osteoid matrix in vivo (15).
Conclusions
In summary, the BFP is a simple procedure, widely 
applicable with low incidence of failure and minimal 
donor site morbidity that may be recommended when 
surgery in upper maxilla in BRONJ patients is planned. 
This technique could reduce or avoid postsurgical OAC 
and promote bone healing in the affected area.
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